Status:
TERMINATED
Assessing Performance on Speech Tasks Via Crowdsourced Participants
Lead Sponsor:
Novoic Limited
Conditions:
Cognitive Impairment
Mild Cognitive Impairment
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to examine the properties of the Automatic Story Recall Test (ASRT) and its parallel variants, as well as letter fluency and category fluency cognitive tests. Tests will be...
Detailed Description
The AMYWEB study will validate speech tasks developed by NOVOIC in different population samples, including normative samples, samples recruited for enhanced demographic diversity, and participants wit...
Eligibility Criteria
Inclusion
- First language must be English
- Residing in the USA
- Willing to participate in a study investigating speech and dementia
- Able to provide informed consent
- Access to personal computing device that is capable of audio and video recording, and able to connect to the internet
- Since key research questions are focused primarily on older-age speech and cognition, initial recruitment will be focused on older adult age brackets, which may be extended to younger adulthood if the desired sample sizes are not attained.
Exclusion
- No formal exclusion criteria will apply at the point of recruitment and testing. however, participants with a reported history of neurological conditions or head injury, and current depression will be excluded from normative data development.
Key Trial Info
Start Date :
April 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2022
Estimated Enrollment :
1034 Patients enrolled
Trial Details
Trial ID
NCT05298501
Start Date
April 5 2022
End Date
July 8 2022
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novoic Ltd
London, United Kingdom